Literature DB >> 14752378

[Neurosurgical management of spontaneous cerebral hemorrhage].

J P Lejeune1, L Thines.   

Abstract

Intracerebral hemorrhage (ICH) accounts for 10 to 20% of strokes, but carries the highest rate of morbidity and mortality. Until now, there is no proven benefit in the literature for surgical treatment of ICH, and management of ICH varies greatly in neurosurgical centers. Surgery can be performed through standard craniotomy, or with a stereotactic procedure for deep-seated ICH. Conscious patients with minimal neurological deficit and small ICH are nonsurgical candidates. Patients with a Glasgow Coma Score lower than 4, with large deep-seated ICH are also non surgical candidates. In other situations, the following arguments could lead to the decision of surgery: superficial (so-called lobar) ICH, size above 3 cm in diameter, midline shift, secondary neurological worsening, young patient, underlying vascular malformation. Acute hydrocephalus from ventricular hemorrhage may be treated with external ventricular drainage if the associated deep-seated ICH is small in size. Indications of surgery are more frequent for cerebellar ICH, as the risks for brainstem compression and hydrocephalus from ventricular obstruction are important.

Entities:  

Mesh:

Year:  2003        PMID: 14752378

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  3 in total

1.  Clinical study to assess the outcome in surgically managed patients of spontaneous intracerebral hemorrhage.

Authors:  Yashwanth S Sandeep; M Raja Guru; Ranjan Kumar Jena; Veldurti Ananta Kiran Kumar; Amit Agrawal
Journal:  Int J Crit Illn Inj Sci       Date:  2017 Oct-Dec

2.  Surgical Outcome of Spontaneous Supra Tentorial Intracerebral Hemorrhage.

Authors:  Waqar Aziz Rehman; Muhammad Sohaib Anwar
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

Review 3.  Rehabilitation training combined acupuncture for limb hemiplegia caused by cerebral hemorrhage: A protocol for a systematic review of randomized controlled trial.

Authors:  Guang-Fu Song; Cheng-Ji Wu; Shu-Xin Dong; Chang-Hong Yu; Xin Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.